Get the Stockscreener App
4.71
3.06%
0.14
After Hours:
4.69
-0.02
-0.42%
Goodrx Holdings Inc stock is traded at $4.71, with a volume of 1.46M.
It is up +3.06% in the last 24 hours and up +6.08% over the past month.
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
See More
Previous Close:
$4.57
Open:
$4.6
24h Volume:
1.46M
Relative Volume:
1.04
Market Cap:
$1.80B
Revenue:
$775.09M
Net Income/Loss:
$-58.68M
P/E Ratio:
-35.52
EPS:
-0.1326
Net Cash Flow:
$64.06M
1W Performance:
+13.49%
1M Performance:
+6.08%
6M Performance:
-44.59%
1Y Performance:
-26.75%
1-Day Range:
$4.59
$4.89
1-Week Range:
$4.19
$4.89
52-Week Range:
$4.09
$9.2599
Goodrx Holdings Inc Stock (GDRX) Company Profile
Name
Goodrx Holdings Inc
Sector
Industry
Phone
(855) 268-2822
Address
2701 OLYMPIC BOULEVARD, SANTA MONICA
Compare GDRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GDRX
Goodrx Holdings Inc
|
4.71 | 1.80B | 775.09M | -58.68M | 64.06M | -0.1326 |
|
VEEV
Veeva Systems Inc
|
223.04 | 36.21B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
74.02 | 12.79B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
55.52 | 10.37B | 516.85M | 174.11M | 217.38M | 0.87 |
|
HQY
Healthequity Inc
|
104.74 | 9.08B | 1.15B | 96.70M | -161.99M | 1.09 |
|
TEM
Tempus Ai Inc
|
47.64 | 7.50B | 640.44M | -743.28M | -206.93M | -11.29 |
Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Aug-09-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| May-23-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| May-16-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Apr-10-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-25-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-01-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-02-24 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-10-23 | Upgrade | DA Davidson | Neutral → Buy |
| Jul-31-23 | Upgrade | TD Cowen | Market Perform → Outperform |
| Dec-01-22 | Initiated | Citigroup | Buy |
| Nov-04-22 | Upgrade | JP Morgan | Underweight → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-12-22 | Initiated | DA Davidson | Neutral |
| Jun-10-22 | Downgrade | Goldman | Buy → Neutral |
| Jun-06-22 | Resumed | BofA Securities | Buy |
| Jun-01-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-10-22 | Downgrade | Evercore ISI | Outperform → In-line |
| May-10-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| May-10-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-10-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-11-22 | Initiated | Wells Fargo | Equal Weight |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Neutral |
| Mar-15-22 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-01-22 | Reiterated | Barclays | Overweight |
| Mar-01-22 | Reiterated | BofA Securities | Neutral |
| Mar-01-22 | Downgrade | Cowen | Outperform → Market Perform |
| Mar-01-22 | Downgrade | Credit Suisse | Outperform → Neutral |
| Mar-01-22 | Reiterated | Evercore ISI | Outperform |
| Mar-01-22 | Reiterated | Goldman | Buy |
| Mar-01-22 | Reiterated | JP Morgan | Underweight |
| Mar-01-22 | Reiterated | RBC Capital Mkts | Outperform |
| Mar-01-22 | Reiterated | SVB Leerink | Outperform |
| Jan-07-22 | Initiated | Goldman | Buy |
| Dec-21-21 | Initiated | Stephens | Overweight |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Aug-31-21 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-13-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-28-21 | Initiated | Robert W. Baird | Neutral |
| Apr-06-21 | Resumed | Evercore ISI | Outperform |
| Jan-25-21 | Initiated | Guggenheim | Buy |
| Nov-19-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-18-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-19-20 | Initiated | Barclays | Equal Weight |
| Oct-19-20 | Initiated | BofA Securities | Neutral |
| Oct-19-20 | Initiated | Citigroup | Buy |
| Oct-19-20 | Initiated | Cowen | Outperform |
| Oct-19-20 | Initiated | Credit Suisse | Outperform |
| Oct-19-20 | Initiated | Deutsche Bank | Hold |
| Oct-19-20 | Initiated | Goldman | Neutral |
| Oct-19-20 | Initiated | JP Morgan | Neutral |
| Oct-19-20 | Initiated | Morgan Stanley | Overweight |
| Oct-19-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-19-20 | Initiated | SVB Leerink | Outperform |
| Oct-19-20 | Initiated | UBS | Buy |
View All
Goodrx Holdings Inc Stock (GDRX) Latest News
Short Interest in GoodRx Holdings, Inc. (NASDAQ:GDRX) Declines By 5.8% - MarketBeat
GoodRx Holdings, Inc. Announces CFO Changes, Effective January 17, 2025 - Marketscreener.com
GoodRx Holdings, Inc. (NASDAQ:GDRX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
GoodRx Holdings, Inc. (NASDAQ:GDRX) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
Barclays PLC Grows Position in GoodRx Holdings, Inc. (NASDAQ:GDRX) - Defense World
GoodRx Holdings, Inc. (NASDAQ:GDRX) Shares Acquired by Barclays PLC - MarketBeat
GoodRx Holdings announces CFO resignation; shares drop - MSN
GoodRx (NASDAQ:GDRX) Stock Price Down 8.4% Following Analyst Downgrade - Defense World
GoodRx stock falls on CFO resignation news By Investing.com - Investing.com Canada
More Zero-cost Virtual Healthcare Appointments Available to Those Affected by Wildfires in Southern California - GlobeNewswire Inc.
GoodRx Holdings CFO Resigns, Interim CFO Appointed - TipRanks
GoodRx (NASDAQ:GDRX) Price Target Lowered to $6.25 at Citigroup - MarketBeat
GoodRx (NASDAQ:GDRX) Stock Price Up 5.8%Should You Buy? - MarketBeat
GoodRx (NASDAQ:GDRX) Price Target Lowered to $6.00 at KeyCorp - MarketBeat
Assessing GoodRx Holdings: Insights From 4 Financial Analysts - Benzinga
GoodRx: A Business In Transition, But It Has Likely Reached Its Low (Rating Upgrade) - Seeking Alpha
GoodRx Unleashes “GoodRx for Pets,” Simplifying Access and Reducing Costs for Pet Medications - Marketscreener.com
GoodRx Unleashes "GoodRx for Pets," Simplifying Access and Reducing Costs for Pet Medications - Quantisnow
WM Technology Names Former Cerebral CTO Sarah Griffis to Lead Technology Innovation - StockTitan
Jane Street Group LLC Sells 38,269 Shares of GoodRx Holdings, Inc. (NASDAQ:GDRX) - Defense World
GoodRx (NASDAQ:GDRX) Sees Strong Trading VolumeHere's Why - MarketBeat
GoodRx Holdings, Inc. (NASDAQ:GDRX) Short Interest Update - MarketBeat
Exploring 3 Prominent High Growth Tech Stocks In The United States - Yahoo Finance
Barclays PLC Has $973,000 Stake in GoodRx Holdings, Inc. (NASDAQ:GDRX) - Defense World
Sanctuary Advisors LLC Invests $85,000 in GoodRx Holdings, Inc. (NASDAQ:GDRX) - Defense World
GoodRx Taps Pharmacy Benefits Exec as CEO - Los Angeles Business Journal
State Street Corp Sells 262,022 Shares of GoodRx Holdings, Inc. (NASDAQ:GDRX) - MarketBeat
State Street Corp Decreases Stake in GoodRx Holdings, Inc. (NASDAQ:GDRX) - Defense World
GoodRx (NASDAQ:GDRX) Trading Up 2%Here's What Happened - MarketBeat
GoodRx stock removed from Raymond James' Favorites list - Investing.com India
GoodRx stock removed from Raymond James’ Favorites list By Investing.com - Investing.com Nigeria
GoodRx stock removed from Raymond James' Favorites list By Investing.com - Investing.com South Africa
Raymond James adds UnitedHealth, drops GoodRx from favorites list - Seeking Alpha
Franklin Resources Inc. Makes New $5.68 Million Investment in GoodRx Holdings, Inc. (NASDAQ:GDRX) - MarketBeat
GoodRx Holdings, Inc. (NASDAQ:GDRX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
GoodRx to Present at J.P. Morgan's Prestigious Healthcare Conference in January 2025 - StockTitan
GoodRx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - Business Wire
GoodRx Holdings, Inc. Appoints Wendy Barnes as CEO Starting January 1, 2025 - Marketscreener.com
GoodRx names new CEO - Houston Business Journal
GoodRx names Wendy Barnes as new CEO and President By Investing.com - Investing.com Australia
Morgan Stanley Has Lowered Expectations for GoodRx (NASDAQ:GDRX) Stock Price - MarketBeat
GoodRx stock rises 5% after new CEO appointment By Investing.com - Investing.com Australia
GoodRx Report: 70% of U.S. Counties Face Critical Endocrinologist Shortage, 50M Americans Affected - StockTitan
GoodRx stock rises 5% after new CEO appointment - Investing.com
GoodRx appoints PBM veteran Wendy Barnes as CEO—Wells Fargo bullish on stock - Investing.com
GoodRx names Wendy Barnes as new CEO and President - Investing.com
GoodRx Holdings Appoints Wendy Barnes as CEO - TipRanks
GoodRx Names Wendy Barnes as New CEO - MarketWatch
GoodRx appoints Wendy Barnes as new CEO - Investing.com
GoodRx Appoints Healthcare Industry Veteran, Wendy Barnes, as New Chief Executive Officer - Nasdaq
Charles Schwab Investment Management Inc. Boosts Stake in GoodRx Holdings, Inc. (NASDAQ:GDRX) - Defense World
Goodrx Holdings Inc Stock (GDRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
7.02%
1.52%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):